We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6724:TSESeiko Epson Corp. Analysis

Data as of 2026-03-11 - not real-time

¥2,009.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Seiko Epson is trading at ¥2,009.5, comfortably above the 200‑day SMA (¥1,947) but below the 20‑day SMA (¥2,069), indicating a short‑term pull‑back within a longer‑term bullish framework. The RSI sits at 45, suggesting neutral momentum, while the MACD is in bearish territory, warning of possible downside pressure. Support is anchored around ¥1,926 and resistance near ¥2,207, giving the stock a modest upside of roughly 8% based on the DCF fair value of ¥2,039. Valuation appears attractive: a trailing P/E of 12.7 is far below the industry average of 37, and the P/B of 0.75 signals a discount to book. The dividend yield of 3.72% with a 47% payout ratio is supported by strong cash generation (¥91.5 bn operating cash flow) and a solid balance sheet. Revenue growth of 7.7% and a forward EPS outlook of ¥202 point to steady earnings expansion. The company’s diversified exposure across printing, visual communications, and industrial robotics mitigates segment‑specific risk.
Overall, the stock presents a compelling blend of value and modest growth, underpinned by a sustainable dividend and a low‑beta (0.75) profile. While technical signals are mixed, the fundamental backdrop and modest upside make it a prudent hold‑to‑buy candidate for medium‑ and long‑term investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term support levels
  • Bearish MACD histogram
  • Stable trading volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to industry peers
  • Attractive dividend yield with sustainable payout
  • DCF upside potential of ~8%

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent revenue and earnings growth
  • Diversified product portfolio across multiple tech segments
  • Strong cash position and low leverage

Key Metrics & Analysis

Financial Health

Revenue Growth7.70%
Profit Margin3.13%
P/E Ratio12.7
ROE5.12%
ROA3.42%
Debt/Equity26.00
P/B Ratio0.8
Op. Cash Flow¥91.5B
Free Cash Flow¥32.2B
Industry P/E37.0

Technical Analysis

TrendBullish
RSI45.4
Support¥1,926.00
Resistance¥2,206.50
MA 20¥2,068.93
MA 50¥2,038.47
MA 200¥1,947.24
MACDBearish
VolumeStable
Fear & Greed Index77.82

Valuation

Fair Value¥2,039.34
Target Price¥2,175.00
Upside/Downside8.24%
GradeUndervalued
TypeValue
Dividend Yield3.72%

Risk Assessment

Beta0.75
Volatility29.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.